Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
eli lilly
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
2
×
san francisco top stories
sanofi
2
×
vaccines
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
bill cassidy
biogen
biontech
biotech
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
caelum biosciences
cancer
cancer immunotherapy
celgene
chuck grassley
corvus pharmaceuticals
crenezumab
curevac
dengue fever
What
bio
companies
2
×
latest
pharmaceutical
2
×
alzheimer’s
bets
cancer
comes
cut
date
deal
different
drug
effective
enticed
evidence
fail
gene
hasn’t
increases
medicines
messenger
molecules
mrna
multiple
new
plan
prescription
price
prices
primarily
promise
proven
raise
rna
roundup
sanofi
second
source
start
Language
Current search:
sanofi
×
companies
×
pharmaceutical
×
" san francisco blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines